RSS

spinal muscular atrophy (SMA)

The CHMP has given a positive opinion recommending that Biogen’s treatment for patients with spinal muscular atrophy (SMA), SPINRAZA (nusinersen), be granted marketing authorisation. more

24 Apr 2017 12:08 News